Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Hepatitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Hepatitis C Virus (HCV) in Decompensated Liver Cirrhosis
Journal:
Internal medicine (Tokyo, Japan)
Treatment Used:
Ledipasvir and Sofosbuvir
Number of Patients:
1
Published —
March 01, 2021
This case report describes a 76-year-old woman with hepatitis C virus (HCV) with decompensated liver cirrhosis treated with ledipasvir and sofosbuvir.
Condition:
Patients with Chronic Hepatitis C Virus (HCV) Infection in Belgium
Journal:
Acta gastro-enterologica Belgica
Treatment Used:
Second-Generation Direct-Acting Antiviral (DAA) Regimens
Number of Patients:
405
Published —
February 28, 2021
This study described the comorbidities and concomitant medications in patients initiating treatment for hepatitis C virus (HCV) infection with direct-acting antiviral (DAA) regimens in Belgium.
Condition:
Chronic Hepatitis C
Journal:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Treatment Used:
Ledipasvir plus Sofosbuvir versus Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir
Number of Patients:
4352
Published —
February 24, 2021
In this study, researchers compared the outcomes of using of ledipasvir plus sofosbuvir versus ombitasvir/paritaprevir/ritonavir/dasabuvir for the treatment of chronic hepatitis C.
Condition:
Hepatitis C Virus
Journal:
Global heart
Treatment Used:
Directly Acting Antiviral Treatment
Number of Patients:
400
Published —
February 18, 2021
The study researched the outcomes of directly acting antiviral treatment for treating hepatitis C virus.
Condition:
Hepatitis C Patients with Advanced Chronic Kidney Disease
Journal:
PloS one
Treatment Used:
Sofosbuvir
Number of Patients:
1464
Published —
February 10, 2021
The aim of this study was to evaluate the effectiveness and safety of Sofosbuvir-based therapy without Ribavirin for hepatitis C infected patients with advanced chronic kidney disease (CKD).
Condition:
Adolescents and Children with Chronic Hepatitis C (CHC)
Journal:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Treatment Used:
Sofosbuvir-Based Regimens
Number of Patients:
0
Published —
February 07, 2021
This article discusses the use of sofosbuvir-based regimens in the treatment of adolescents and children with chronic hepatitis C (CHC).
Condition:
Hepatocellular Carcinoma and Hypersplenism
Journal:
Medicine
Treatment Used:
Splenectomy before Hepatectomy
Number of Patients:
266
Published —
February 03, 2021
The study researched the outcomes of splenectomy before hepatectomy in patients with hepatocellular carcinoma and hypersplenism.
Condition:
Chronic Hepatitis C in Liver Transplant Recipients
Journal:
Revista do Instituto de Medicina Tropical de Sao Paulo
Treatment Used:
Direct Acting Antivirals
Number of Patients:
84
Published —
February 03, 2021
This study evaluated the effectiveness of direct acting antivirals (DAAs) for the treatment of chronic hepatitis C (CHC) in liver transplant recipients.
Condition:
Hepatitis Associated Aplastic Anemia (HAAA)
Journal:
Cell transplantation
Treatment Used:
Umbilical Cord-Derived Mesenchymal Stromal Cells (UC-MSCs) Infusion and Cyclosporine A (CsA)
Number of Patients:
NULL
Published —
February 02, 2021
This article reviewed the case of a patient with severe hepatitis (inflammation of the liver tissue) associated aplastic anemia (condition that occurs when the body stops producing enough new blood cells; HAAA) treated with umbilical cord-derived mesenchymal stromal cells (cells found throughout the body tissues that are essential for producing and repairing structural such as cartilage, bone, and fat; UC-MSCs) infusion and cyclosporine A (CsA).
Condition:
Mother's Breast Milk Odor
Journal:
BMC pediatrics
Treatment Used:
Pain from Hepatitis B Vaccine
Number of Patients:
90
Published —
February 01, 2021
This study tested the safety and efficacy of using mother's breast milk odor to reduce pain during the hepatitis B vaccine for preterm infants.
Condition:
Patients in Switzerland with Chronic Hepatitis C Virus (HCV) Infection
Journal:
Swiss medical weekly
Treatment Used:
Glecaprevir/Pibrentasvir Therapy
Number of Patients:
109
Published —
January 30, 2021
This study evaluated the effectiveness and safety of glecaprevir/pibrentasvir therapy in patients in Switzerland with chronic hepatitis C virus (virus that causes inflammation of the liver; HCV) infection.
Condition:
Thrombocytopenic Chronic Hepatitis C (CHC)Patients
Journal:
BMC gastroenterology
Treatment Used:
Direct-Acting Antiviral Agent (DAA) Therapy
Number of Patients:
104
Published —
January 22, 2021
This study examined the role of baseline (BL) thrombopoietin (TPO) in patients with chronic hepatitis C (CHC) receiving direct-acting antiviral agents (DAA).
Showing 1-12 of 932
Next